TAMPA, Fla. — December 18, 2025 — Leads & Copy — FLUENT Corp. applauds the federal action directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act.
This landmark policy shift formally recognizes cannabis’s accepted medical use and represents a critical step toward a more rational and regulated national cannabis framework.
Interim CEO of FLUENT, David Vautrin, said that federal rescheduling is a pivotal moment for patients, operators, and investors. He added that they applaud the Administration for recognizing the therapeutic benefits of cannabis-based medicine and advancing common-sense reforms, including 280E relief.
According to the company, Schedule III status will reduce federal policy barriers, improve access to banking, and allow companies to deduct ordinary business expenses previously disallowed under 280E, freeing capital for patient care, product innovation, and market expansion.
The company stated that this rescheduling follows recent federal clarification around hemp-derived intoxicants passed on November 12th, 2025, which is expected to materially shut down the depth and reach of intoxicating hemp derived Cannabis by November 2026. This is expected to reduce unlicensed competition and ease pricing pressure enterprise wide with the greatest impact in key FLUENT states such as Florida and the potential in Texas.
Mr. Vautrin added that while rescheduling represents meaningful progress, there remains important work ahead to fully resolve the conflict between state and federal law and to advance broader criminal justice reforms. FLUENT remains committed to operating responsibly within the regulatory framework while supporting continued policy evolution that benefits patients, communities, and investors, he said.
FLUENT is a national cannabis consumer packaged goods company and retailer, is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by FLUENT’s unrelenting commitment to operational excellence in cultivation, production, distribution, and retail experience. FLUENT produces an assortment of cannabis products under a diverse portfolio of brands including MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT operates in Florida, New York, Pennsylvania, and Texas. Headquartered in Tampa, Florida, FLUENT employs 700 employees across 8 cultivation and manufacturing facilities, 37 active retail locations and a wholesale division which trades under ENTOURAGE servicing third party retailers in New York.
Matt Mundy, Chief Legal Officer, (850) 972-8077
Source: FLUENT Corp.
